Immunotherapy
911 articles
The Promise of Organoids
Dr. Brian Wolpin explains how organoids are being used to develop personalized treatment for pancreatic cancer patients.
Periodontal Disease and Pancreatic Cancer?
Did you know that periodontal disease may predict pancreatic cancer? Researchers are finding a link between unhealthy gums and the deadly cancer.
The Cancer Moonshot
Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.
Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer
Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
Could There Be a Cure in Vitamin C?
Vitamin C has been found to kill cancer cells that carry the KRAS mutation. This mutation is common in pancreatic and colorectal cancers.
Testing a Thyroid Cancer Drug to Treat Advanced Pancreatic Neuroendocrine Tumors
Researchers are testing a thyroid drug to see if it is effective against pancreatic neuroendocrine tumors, among other cancers.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Testing Techniques to Remove Stray Pancreatic Cancer Cells After Surgery
Researchers are studying whether peritoneal washing after pancreatic cancer surgery decreases recurrence of the cancer by removing stray cancer cells.
Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers
Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.
Precision Radiotherapy to Make Pancreatic Tumors Removable
A clinical trial tests a precision radiation technique called intensity-modulated radiation therapy against locally advanced pancreatic cancer.
Adding A Noninvasive Surgical Technique to Standard Treatment for Locally Advanced Pancreatic Cancer
A clinical trial compares standard treatment plus irreversible electroporation to standard treatment alone for locally advanced pancreatic cancer.
Comparing Two Types of Radiotherapy for Pancreatic Tumors that Cannot Be Surgically Removed
Researchers are comparing standard radiotherapy treatment with a newer type of radiation that uses heavy ions, for nonsurgical pancreatic cancer patients.
Finding the Best Dose of Radiation and an Experimental Drug
A clinical trial looks for the best dose of an experimental drug to combat the mouth sores that are a side effect of stereotactic body radiation therapy.